TCT 2020: FORECAST Trial Review by Dr. Alasnag & Prof Curzen
Transcatheter Cardiovascular Therapeutics / TCT 2020 Webinar: Dr. Mirvat Alasnag and Cardiologist Nick Curzen analyse the characteristics of the FORECAST trial.
Related Articles
Journal Club: Severe vs Nonsevere Immune Checkpoint Inhibitor-Induced Myocarditis
Join Dr Kevin Schesing (Memorial Sloan Kettering Cancer Center, US), Dr Jose Alvarez-Cardona (New York University School of Medicine, US), Prof Dan Lenihan (Saint Francis…
View from the Thoraxcenter: ACC.24 Late-breaking Science Wrap Up
Unpack ACC.24’s Top Trials with View from the Thoraxcenter!Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive…
TAVI – Is Lifetime Patient Management the Alpha to Omega of Contemporary Practice?
This symposium hosted at Transcatheter Interventions Online 2024 explored cutting-edge advancements in coronary access and valve design within TAVI. The faculty analysed factors affecting
Optimising RAASi Management in Cardiorenal Patients: An Expert Roundtable
Join cardiologists Dr Shelley Zieroth (University of Manitoba, Winnipeg, CA) and Dr Aaron Wong (Princess of Wales Hospital, Wales, UK) and nephrologists Dr Andrew Frankel…
Cardiovascular Toxicity Tumour Board
In this broadcast, Dr Inbar Nardi Agmon (Toronto General Hospital, CA), Prof Joshua Mitchell (Washington University School of Medicine, US) and Dr Clara Llamedo (Royal…
Occupational Dangers of Radiation
In this broadcast, our distinguished panel delve into the dangers of radiation within cardiovascular laboratories and explore emerging solutions to address these critical concerns.
Cardiovascular Toxicity Tumour Board
In this broadcast, Dr Inbar Nardi Agmon (Toronto General Hospital, CA), Prof Joshua Mitchell (Washington University School of Medicine, US) and Dr Clara Llamedo (Royal…
ACC.2024: Percutaneous transvalvular micro-axial flow pump in infarct related cardiogenic shock: Results of the DANGER-shock Trial
Mirvat Alasnag interviews Jacob Eifer Møller about the results of the DANGER-shock Trial which he presented at the ACC.24. Implantation of microaxial flow pump post-heart…
ACC.2024 – Empagliflozin after acute myocardial infarction: Results of the EMPACT-MI Trial
Mirvat Alasnag interviews Javed Butler about the EMPACT-MI trial which he presented at ACC.24. Among patients at increased risk for heart failure after acute MI,…
Join our Cloud HD Video Meeting
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile,…